William D Baird III insider trades

Open-market stock purchases and sales by William D Baird III, President and CEO at 2seventy bio, Inc, from SEC Form 4 filings since Apr 18, 2012.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +109%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • TSVT 2seventy bio, Inc: 14 sales, last May 13, 2025
  • AXLA Axcella Health Inc: other filings, last May 19, 2022
  • BLUE bluebird bio, Inc: 5 sales, last Nov 11, 2021
  • FOLD Amicus Therapeutics Inc: 3 buys, 15 sales, last Oct 15, 2018

Get free alerts when William D Baird III files a new trade →